Arkiv för ‘Loggboken’ Category

Blog Post Number 400: PiE in Parliament

Kategorier:

Swedish parliament house

Swedish parliament house

If you read my blog post yesterday, you’ll know that I spoke with the All Party Committee on Environmental Objectives today in Swedish parliament. The topic was PiE, i.e. Pharmaceuticals in the Environment, or actually Pharmaceuticals and the Environment since we discussed not only pharmaceutical substances released into the environment from manufacturing or patient excretion but all different environmental aspects and pharmaceuticals. And I have to say that it is quite a coincident that such an important and interesting discussion takes place the day I write my 400th blog post!

I have had this blog since April 2008, and the topic “Pharmaceuticals and the Environment” has been one of the topics most frequently addressed. And today’s presentation in parliament discussed several of the issues that I have commented in blog posts over the years, e.g.

- Economic incentives for green pharmaceutiacls (read more in e.g. these blog posts: March 28 2011, Feb 23 2011)

- Releases of API (Active Pharmaceuticals Ingriedient) from manufacturing (read more in e.g. these blog posts: Aug 16 2010, Sept 10 2010)

- Swedish MPA’s proposal of inclusion of environmental requirements into GMP (Good Manufacturing Practice) (read more in e.g. this blog post: Jan 5 2011)

- Environmental classification of pharmaceutical substances on fass.se

- Green Chemistry (read more in this blog post or on Pfizer’s global webpage)

As you saw in the end of yesterday’s blog post, my two key messages today were:

1. Never deny a patient valuable medical treatment due to environmental reasons. Patient safety shall always come first.
2. The All Party Committee should look upon and use all ongoing initiatives rather than initiate several new initiatives. The most important thing the All Party Committee could do regarding pharmaceuticals and environment is actually to secure that the “right political signals for action” are being sent!

And the “ongoing initiatives” that I refer to are of course the discussions on green economic incentives, MPA’s proposal regarding GMP-alterations, and the actions discussed in the Swedish National Pharmaceutical Strategy.

I am looking forward to continuing discussions with the All Party Committee on Environmental Objectives and thanks for the opportunity to give my reflections on Pharmaceuticals and the Environment in parliament today!

The parliament building

The parliament building

Postat av Bengt Mattson

| Kommenterer (0)

An Enterprise 2020 Company - what is that?

Kategorier:

CSR Sweden arranged a breakfast seminar today where CSR Europe’s Executive President Stefan Crets presented the “Enterprise 2020 Initiative“.

Stefan Crets, CSR Europe

Stefan Crets, CSR Europe

In Stefan Crets’ words, “CSR Europe is not a lobbying organization, and it is not a think tank. It is a platform for a change of society and business practices based on sharing and further development of CSR best practices and knowledge with peers and stakeholders”. And for sure, such a platform is really needed. A focus on sharing practical experiences, rather than just theroretical and sometimes even just semantic issues, is definitely welcome. 

And I have to say, that I really like the initiative taken by CSR Europe on building “Enterprise 2020 Companies”. So what is an Enterprise 2020 Company?

A company must develop its business strategies based on an understanding on how the world will look like in the future. Let’s say 2020. How will trends such as increasing globalisation, demographic change, natural resource scarcity, technology acceleration, global health challenges and social divisions shape business and society? How will the trends influence the capacity of the company and the organisation to create value that contributes to economic, societal and environmental progress?

Global Policy Development

Global Policy Development

In order to fully understand how these global challenges affect business strategies companies also need to understand how those trends affect Global Policy Developments, e.g. ISO 26000, UN Global Compact, GRI on the international level and on a European level e.g. the Europe 2020 Strategy, New EU Communication on CSR (due October 2011), and a legislative proposal on CSR Reporting (due 2012).

EU Policy Development

EU Policy Development

Stefan Crets describes an Enterprise 2020 company as a company that has fully integrated CSR into its business strategies, so business contributes to a SMART, SUSTAINABLE, and INCLUSIVE growth. In order to be successful, social innovation is a key. Social innovation means new ideas, business models, and products and services resolving existing sustainable challenges such as demographic change, human rights violations, finacial crise, environmental degradation, and poverty.

These ideas is nicely aligned with the “more-than-medication”-strategy for the pharmaceutical industry that I have elaborated upon previously here at the blog:

- The need to fully integrate the CSR startegies into the business strategies of the company (see e.g. blog post from March 29, 2010 (it is in Swedish, sorry for that!))

- 4 steps to a sustainable use of pharmaceuticals (see e.g. blog post from Feb 8, 2011)

- The need for, and opportunities with, social innovation (see e.g. blog post from April 8, 2011)

Enterprise 2020 Company - well, we are not there yet, but we are moving in the right direction…

Postat av Bengt Mattson

| Kommenterer (0)

Sharing our CSR programs with colleagues

Kategorier:

Our best Corporate Social Responsibility (CSR) ambassadors are of course our own colleagues. They meet customers and other stakeholders, including their own friends and families, on a daily basis. Their knowledge and participation is crucial for our success in interactively spreading the information about our environmental and social sustainability programs. It is also obvious that lack of knowledge, understanding and information among our collegues about those programs would make all CSR communication via web-pages etc look like a “fake facade without any content”…

Hence, I am happy to see, and participate myself of course, that our CSR programs are being shared with our colleagues. During this week at the “kick-off autumn conference” at Hasseludden outside Stockholm. There has been e.g. good opportunities for our collegues to visit a booth where Kristina Sandberg and others have shown Pfizer’s different products and services in addition to the medicines themselves. In the picture below, you’ll see Kristina presenting a brochure called “Pfizer och Ansvarsfullt Företagande - en introduktion till Pfizers hållbarhetsarbete” (in English roughly “Pfizer and Corporate Responsibility - an introduction to Pfizer’s Sustainability Programs).

Discussions about CSR-programs

Discussions about CSR-programs

The broschure is a very brief introduction which is intended to guide the reader to the CSR and sustainability information on pfizer.se. There you will find information in three levels - an introduction on Level 1, some more information about the programs on Level 2, and details on Level 3.

The CSR brochure

The CSR brochure

Visitors to the “more than medication-booth” were guided by a sign proclaiming “The grass is really greener here”. A funny and smart sign in my opinion!

The grass is greener here

The grass is greener here

I have given presentations in some more depth to colleagues. Important slides in those presentations are some of my old favourites that you will know if you have read my blog previosuly.

Giving a lecture on CSR

Giving a lecture on CSR

There was of course the slide about the “Sustainable Quadrant” that I have borrowed from Stina Billinger from SPP:

The Sustainable Quadrant

The Sustainable Quadrant

There was of course also the Walderik-Mattson pyramid:

Walderik-Mattson pyramid

Walderik-Mattson pyramid

These days have been fun and as I said in the beginning of the blog post, very important. Our colleagues are our strongest and most crucial ambassadors!

Postat av Bengt Mattson

| Kommenterer (0)

Back from summer vacation 2011…

Kategorier:

So, after four weeks of vacation I arrived back to the office today. Vacation has been very good - one of the top moments for me this year was when I played my violin on top of Åreskutan.

Playing the violin at Åreskutan

Playing the violin at Åreskutan

So what to expect work-wise this autumn. Well, of course there will be a lot of discussions around the proposal from Swedish MPA to include environmental requirements in GMP (Good Manufacturing Practice), and the alternative or complementary approach to implement green incentives into the pricing and re-imbursement system in order to reward green and sustainable initiatives and products. Read more about these ideas, and follow the links to further information, in my blog post from July 19. You can also listen to the video-blog I recorded during the political summit in Almedalen in July where I discuss the issues around a “green pharmaceutical market”. If you are interested in general what’s going on in relation to social and environmental sustainability in Sweden I recommend you to screen through my updates from the Almedalen week via these links:

- July 3 in Almedalen

- July 4 in Almedalen

- July 5 in Almedalen

- July 6 in Almedalen

- July 7 and 8 in Almedalen

In addition to the discussions on GMP and green economic incentives with MPA, TLV (The Dental and Pharmaceutical Benefits Agency, responsible for the pricing and re-imbursement system) and other stakeholders there will also be further discussions with the All-Party Committee on Environmental Objectives regarding the Swedish national environmental goal on a Non-Toxic Environment. To read more about that, see e.g. my blog post from June 15.

I am also convinced that we will participate in several discussions with a wide range of stakeholders regarding social innovation and social entrepreneurship. If you have followed me on the blog post during recent years you know that I strongly believe that we will see changes in the pharmaceutical market. There will be more interest in services, and hence not only “pills and medication”, and more and more on prevention and creation of wellness. Read more in my blog post from April 8, and via the link more-than-medication.

And last but not least there will of course be a lot of work on Dizza Tobak.

Dizza Tobak is a three year project, run by SAMBA in collaboration with among others A Non Smoking Generation, and sponsored by Pfizer Foundation and Pfizer AB. We are now entering into the final months of the project (ending Dec 2011) and there will be a lot of work summarizing the project, doing lessons learned sessions, and securing a future of the successful parts of the project together with A Non Smoking Generation. Please view some of the up-loaded contributions from this spring via this link. It is fun, educating, and very often really impressing!

Postat av Bengt Mattson

| Kommenterer (0)

Thursday and Friday July 7-8, 2011, in Almedalen

Kategorier:

It is Friday morning in Visby. For me it is the last day here at the political summit in Almedalen.

Sun is shining in Almedalen

Sun is shining in Almedalen

My reflections on seminars and discussions from the previous days of the “Almedalen week” can be found via this links:

- Sunday July 3

- Monday July 4

- Tuesday July 5

- Wednesday July 6

So, let me first give some general reflections on this week and then comment on some of the seminars seminars from yesterday (i.e. Thursday July 7).

It has been a hectic week, with an enormous amount of different seminars to visit. In total around 1500 events… How do you manage to find the golden eggs in such a big basket? A whole range of seminars has been related to environmental and social responsibility issues, and there has also been a number of healthcare and illness prevention related ones. Hence, really good possibilities for me to become educated and stimulated!

I have had my son Christoffer with me during the week and for him it is like “democracy school”. Where would you be able to see and participate in so many interactions between all different stakeholders in society, e.g. politicians, NGOs, industry representatives etc.? But if you read his blog, you will notice that he has not been fully focused on the things on-going here in Almedalen…

Perhaps the most important thing I bring back from the CSR and environmentally related seminars is some kind of consensus from most stakeholders that regulatory initiatives must be supplemented with market-driven types of solutions. One example of such market-driven ideas are the green incentives I speak about in the video blog I recorded this week.

Recording of the video blog

Recording of the video blog

You will find this video blog, and other Pfizer video blogs from Almedalen, at pfizer.se as well.

I am also happy to see that health related issues have been widely discussed during the week. Large parts of these discussions have been upon prevention of illnesses and promotion of health and wellbeing. If you have followed my blog, you know I feel strongly about the need for more focus on prevention and on health promotion. To me that is an important first step to reach a long term sustainable use of pharmaceuticals. Read more via this link.

Sustainable health care

Sustainable health care

So, in more details what happened in Almedalen yesterday? The first seminar I visited yesterday, “CSR - samhällsansvar med många vinnare” was arranged by Fryshuset and CSR Sweden. Ingvar Nilsson gave an introduction where he pointed out the necessity of actions being undertaken in order to stop kids from ending up “outside” the society. 13000 kids, every year, do not “fit in”. The costs for society, in addition to the human tragedies, are huge: 6 billions SEK every year for those kids. Over a life time that sums up to 150 billions SEK. And next year 13000 addition kids will fall ouside of society… To read more about Ingvar’s data follow this link.

Ingvar Nilsson

Ingvar Nilsson

So what can be done? A panel consisting of representatives from Fryshuset and from some of their industry collaborators, e.g. Stina Billinger from SPP, gave their views. The story to bring home from the discussion is that industry participates in this work not due to “charity reasons”, rather due to “survival reasons”. Industry needs these kids as future employees or as future partners or customers. And we cannot do business in a society where crime prevails and society institutions break down. Industry is a part of society - hence, industry’s CSR initiatives are here to stay! And to be honest - they have always been here, long before the term CSR was born. More on that very soon…

Before the next CSR Sweden seminar, “CSR - behövs piska eller morot” where I was on the panel, I ran over to a seminar arranged by Apoteket AB regarding increased illness among kids: “Vad är orsaken till ökad ohälsa bland barn?”. Presentation were given by, among otehrs, Stephan Rössner and Per Gärdsell.

Per Gärdsell

Per Gärdsell

Per presented the “Bunkeflomodellen”, stressing the importance of health and wellness promotion. Read more on the model via this link. Although not rocket science actually, it is extremely interesting! And it drives me to once again use my old credo:

…För övrigt anser jag att hälsa bör finnas med på schemat…

Time for the next CSR Sweden seminar asking the question whether CSR-initiatives are best develop via legislation or via incentives - “CSR, behövs piska eller morot”.

CSR Sweden panel

CSR Sweden panel

The panel consisted of politicians, Sofia Arkelsten (m) and Rebecka Carlsson (mp), of Niclas Mattsson from the magazine Entreprenör, and myself, Lars Lööv from Samhall, Stina Bilinger from SPP, and Helena Karlsson from Telge Återvinning representing CSR Sweden member companies.

It became a discussion full of energy, much thanks to, or due to, Nicklas Mattson. He dared to be very provocative, which is perhaps not always “politically correct” but it surely helps energizing the debate… Nicklas argues that CSR is being pushed onto companies by a “CSR-mob”, and is a very strong advocate for no regulations what so ever around CSR. CSR should be something driven by the companies themselves, in the interest of the companies, the revenues and the shareholders. As the way this kind of initiatives have always been - long time before they were called CSR-initiatives.

As I said it was an intensive debate and I presume it is fair to summarize that all of us in the panel, perhaps except Nicklas, concluded that there is room for a regulatory framework creating a platform from where companies build their own volontary initiatives. Not very surprising we had somewhat different opinions on the amount of regulations, “how high should the bar be set”, but in general a joint understanding.

I probably say something on incentives

I probably say something on incentives

My key message was once again the importance of incentives to “the good guys”. And I argued that if environmental and social responsibility issues are included in tender business for instance, it is of course fair that industry expects that the responses we develop describing our environmental and CSR records should be taken into account. To often I feel that county councils and other public buyers in reality only care about lowest possible prize. To read more about green criteria and green incentives on the pharmaceutical market, see for instance my blog post from March 28 or the video blog recorded July 5.

Christina Åkerman and Erik Blix

Christina Åkerman and Erik Blix

I then participated in the Pfizer seminar regarding the Swedish national pharmaceutical strategy. Erik Blix led a discussion on the strategy with Christina Åkerman, Director General at Swedish MPA, patients, and politicians. You can read more about this debate at pfizer.se.

My last seminar yesterday was a debate between the party secretaries for Moderaterna and the Social Democrates, Sofia Arkelsten and Carin Jämtin respectively. The debate was based on descriptions of the state of the world, with global warming and other environmental problems. The descriptions were given by Pär Larshans from Max Hamburgers and Pia Stavås Meier from Red Cross.

Environmental policy

Environmental policy

It was a good discussions where the politicians tried to explain what to expect from politicians and policy and what could not be expected. Both Sofia and Carin felt that their parties and policy in general have an increasing focus on not only environmental issues but on sustainability issues in a broad sense. Of course, a lot more needs to be done to secure the longterm sustainability of our planet, and much is needed on a European and on a global level. Important steps to e taken, but very time consuming. Do we have that time? The panel were in agreement that Sweden as a country and Swedish companies such as Max can and should take the lead and be role models for others. And although you can doubt, based on the failure of the climate meeting in Copenhagen for instance, that countries will come together and take the international initiatives that are needed Carin Jämtin tried to have a positive approach. She said that when the world has been in huge problems, and almost in ruins before, as after World War 2, we did come together and global institutions such as UN and World Bank were established to secure survival. Personally I hope that the world wakes up a little bit earlier this time… Do we really have to see the world in ruins before real actions are taken on an international policy level? Or could perhaps industry’s all initiatives around the globe be the kick-start needed for a real change? Let’s cross our fingers!

After the talk by the Center party leader Maud Olofsson in Almedalen (read more via this link) the evening ended with MiljöAktuellt’s “Environmental party” with a lot of informal meetings and a fun, but rather tough, “question-and-answer” session with politicians.

Politicians at the Environmental Party

Politicians at the Environmental Party

 Two of the politicians on the stage, Roger Tiefensee (c) and Matilda Ernkrans (s), are members of the All Party Committee of Environmental Objectives discussing among other things pharmaceuticals in the environment as part of the NonToxic Environment goal. Read more about this work on my bloig post from June 15, and I am looking forward to continuing the discussions on the topic with Roger, Matilda and their colleagues during fall.

No, now it is time for me to pack my things, start my journey home and leave Almedalen for this year. Thanks to all for a great experience again! I’ll be back next year!

Postat av Bengt Mattson

| Kommenterer (0)